{"id":1014816,"date":"2026-10-28T17:40:52","date_gmt":"2026-10-28T21:40:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"},"modified":"2026-10-28T17:40:52","modified_gmt":"2026-10-28T21:40:52","slug":"ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","title":{"rendered":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SUNNYVALE, Calif., Oct.  28, 2026  (GLOBE NEWSWIRE) &#8212; CeriBell, Inc. (Nasdaq: CBLL) (\u201cCeribell\u201d), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York City. The fireside chat will take place on Wednesday, November 11, 2026, at 7:00 a.m. Pacific Standard Time \/ 10:00 a.m. Eastern Standard Time.<\/p>\n<p>\n        <strong>Event: Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum<\/strong><br \/>\n        <br \/>Date: Wednesday, November 11, 2026<br \/>Time: 7:00 a.m. PST\u00a0\/ 10:00 a.m. EST<\/p>\n<p>A live and archived webcast of the fireside chat will be available in the &#8220;Investor Relations&#8221; section of the Ceribell website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MDM9MrBH4iIJd9SEX4GsHSxKhg_6zE4FR0sIRStvBbt-JZf8Fq7mIVep3wawloiYZjX0eo4S0rtJ2wmw-Mhvs2CFsosKkTcAvxFYd-1tQIkrQoJmiztA-r9PpdzZsrE4zDKhmeISv4bIZ88EB_XTKdfopIWW0-tFm_tud8GUvWWdC7zuz790-zXuHL0T0k1aKoUwMiRlcxMphASdrW6gFYh-sPC9wnBaY4bxjdNm1-VbuKzykq5U-3wer_zi8mPnFZzPS-J_GPJ_RTprJc9zbnAJEOZolyh4JlOlFEf0HBWXRyug7vp4D-BYmJJ74bxUyTbDw2IBj4bsHJpsULz-bNwjJPu2Blz2xGiB3cH_dbq0Ym7mj7Zqf18xygiTm52FEvItGnElNdiLT3-ci-Lt-qkzorHqVmIi8ya5Hfk6iLM8UiXffoS0ucwcT8Wj74_uvBefNN00tfsKjxiF4WtsKxqwv0OIRSyHYa7foQNhx4Dqx1mTwqppPZ2u0ZgCpzI4Mj7Ghal0fgVfbAZJrZg7CfHi5eVbQCh7Cd9_7KfQUSuv5QjLd6aQo-ZTOmKUXeFB\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.ceribell.com\/<\/a>.\u00a0<\/p>\n<p>\n        <strong>About CeriBell, Inc.<\/strong><br \/>\n        <br \/>Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel point-of-care electroencephalography (\u201cEEG\u201d) platform specifically designed to address the unmet needs of patients in the acute-care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (\u201cAI\u201d)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for use in detecting seizure and monitoring delirium in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MDM9MrBH4iIJd9SEX4GsHe1cOMZhKMrQZVdq0WscUWLESCsAaNHY63JwTVy_B1uu1mNMptvtu1qb7ZDO65OweykcIvQgOVOU0W5OgJ9SU10=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.ceribell.com<\/a> or follow the company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8o4MxrOsVljWncMgVTVRut3mMbLByjcgdgp8SKrsS59nuB9s0486hMOKKvFLC38Do6oSD9zeYTWw8y5lpNgDELUMbAepkYs51bue3BQUGPo=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p><strong>Investor Contact<\/strong><br \/>Brian Johnston <br \/>Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-wKczwzgE00f1MxVOL-ZHa3okJMKLptoB54Z5d6YuJiFbjooAimPG5kJoad9uvQZZFS1Av6vxEp6_CHfQxJlQ6_J1GDbTVEMoqhBSeU0pds=\" rel=\"nofollow\" target=\"_blank\">Investors@ceribell.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Laura Hartlieb<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gg7GbnbsT54uV56xsKeiz41_Yox5A3UBkt5wSXot-UkYFk-7LFGnRjL-pN4bLFIghAu0qWOqaU7gsZg6G0TsNn78QyktCcVHfymuPhdBpZs=\" rel=\"nofollow\" target=\"_blank\">Press@ceribell.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmM5YjJiYmUtMGExZS00NmQ4LWJhMjYtNzYzNTY3MTE1NGYyLTEzMDUwNTItMjAyNi0xMC0yOC1lbg==\/tiny\/Ceribell.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) &#8212; CeriBell, Inc. (Nasdaq: CBLL) (\u201cCeribell\u201d), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York City. The fireside chat will take place on Wednesday, November 11, 2026, at 7:00 a.m. Pacific Standard Time \/ 10:00 a.m. Eastern Standard Time. Event: Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum Date: Wednesday, November 11, 2026Time: 7:00 a.m. PST\u00a0\/ 10:00 a.m. EST A live and archived webcast of the fireside chat will be available in the &#8220;Investor Relations&#8221; &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1014816","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) &#8212; CeriBell, Inc. (Nasdaq: CBLL) (\u201cCeribell\u201d), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York City. The fireside chat will take place on Wednesday, November 11, 2026, at 7:00 a.m. Pacific Standard Time \/ 10:00 a.m. Eastern Standard Time. Event: Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum Date: Wednesday, November 11, 2026Time: 7:00 a.m. PST\u00a0\/ 10:00 a.m. EST A live and archived webcast of the fireside chat will be available in the &#8220;Investor Relations&#8221; &hellip; Continue reading &quot;Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-28T21:40:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\",\"datePublished\":\"2026-10-28T21:40:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\",\"name\":\"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=\",\"datePublished\":\"2026-10-28T21:40:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","og_locale":"en_US","og_type":"article","og_title":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk","og_description":"SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) &#8212; CeriBell, Inc. (Nasdaq: CBLL) (\u201cCeribell\u201d), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Scott Blumberg, CFO, will participate in a fireside chat at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York City. The fireside chat will take place on Wednesday, November 11, 2026, at 7:00 a.m. Pacific Standard Time \/ 10:00 a.m. Eastern Standard Time. Event: Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum Date: Wednesday, November 11, 2026Time: 7:00 a.m. PST\u00a0\/ 10:00 a.m. EST A live and archived webcast of the fireside chat will be available in the &#8220;Investor Relations&#8221; &hellip; Continue reading \"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-28T21:40:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum","datePublished":"2026-10-28T21:40:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","name":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=","datePublished":"2026-10-28T21:40:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTQ4OCM3OTE3OTM4IzIyOTM1MDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ceribell-to-participate-in-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1014816"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1014816\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1014816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1014816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1014816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}